Anticipatory response + Methamphetamine
Methamphetamine is known to produce anticipatory response, a multisensory effect. Anticipatory response is a Pavlovian conditioning phenomenon in which the body begins mimicking a substance's effects — such as relaxation, stimulation, or even mild euphoria — in the moments before or during the act of ingestion, before pharmacological action has begun.
About Anticipatory response
Anticipatory response is a fascinating phenomenon that sits at the intersection of pharmacology, behavioral psychology, and the neuroscience of conditioning. It refers to the experience of beginning to feel a substance's effects before the substance has had time to actually work — in the moments leading up to ingestion, during preparation of the dose, or in the first seconds after administration, well before any molecule could have reached the brain. The body, having learned what comes next through repeated experience, essentially starts the process early.
The phenomenon is rooted in classical (Pavlovian) conditioning. Just as Pavlov's dogs learned to salivate at the sound of a bell that reliably preceded food, the human nervous system learns to associate certain environmental cues, rituals, and sensory inputs with the impending arrival of a psychoactive substance. The crinkle of a pill packet, the smell of cannabis, the sight of a needle, the ritual of measuring a dose, even the particular room where use typically occurs — all of these become conditioned stimuli that trigger genuine physiological anticipatory responses. These are not imagined or placebo effects in the dismissive sense; they reflect real, measurable neurochemical changes, particularly indopaminergic reward circuits that fire in anticipation of expected reward.
Research on this phenomenon is well-established in addiction science. Heroin users report that anxiety and withdrawal symptoms begin to diminish the moment they have the drug in hand, before injection. Benzodiazepine-dependent individuals feel calmer as soon as they pop the pill from its blister pack. Stimulant users report a surge of energy and focus while preparing their dose. These responses are bidirectional — the body can also produce compensatory responses that are opposite to the drug's effects, as a form of preemptive tolerance. For example, an opioid user's body may begin upregulating pain sensitivity in anticipation of the analgesic flood, which partly explains why environmental cues associated with past use can trigger powerful cravings and withdrawal symptoms even in long-abstinent individuals.
The anticipatory response is most pronounced in people with regular, repeated exposure to a substance, particularly when use follows consistent rituals or occurs in consistent environments. It is not substance-specific — it occurs across every drug class — but it tends to be most noticeable and most discussed in the context of substances with strong reinforcement profiles: opioids, benzodiazepines, stimulants, nicotine, and alcohol.
Understanding anticipatory responses has important harm reduction implications. This conditioning is a significant component of both craving and relapse. Recovering individuals who encounter the environmental cues associated with past use (places, people, paraphernalia, even times of day) can experience powerful conditioned responses that mimic early effects or withdrawal, making abstinence significantly harder. Cue-exposure therapy and environmental change are strategies that directly address this phenomenon.